Piper Sandler Companies

PIPRNYSEUSD

THESIS ALERT

Email me when the PIPR thesis changes

Evidence-based analysis, not personalized investment advice. Every alert email carries an unsubscribe link.

Follow on X
$66.53
−$0.22 (−0.33%)Today 1M +2.25%
After hours$66.530.00%

Updated Nov 11, 4:00 PM ET · Regular session · May be delayed

Source valuation snapshot. Not a live recalculation.
Latest filed annual earnings; price snapshot date unavailable. Not forward P/E.
Diluted earnings per share from the latest filed annual.
$66.75
Prior regular-session close from the quote source.
$66.28–$67.92
Regular-session low and high so far today.
373.5K
Regular-session shares traded · Nov 11, 4:00 PM ET.
Feb 5 projected
Projected for 2027-02-05 from the company’s own results filings (SEC 8-K Item 2.02). The company has not confirmed the date.
$61.35–$95.07
52-week trading low and high returned by the quote source.

Understand the Business

Why the Stock Moved

Period-matched expectations history is not yet available. Current metrics are not a substitute for a historical explanation.

The core investment thesis

Own PIPR if Piper Sandler compounds value by winning middle-market advisory and public finance mandates, cross-selling institutional brokerage and alternative-asset fees, and using a strong balance sheet to amplify underwriting and selective acquisitions.

PIPR price history

Latest price$66.53Today−$0.22 (-0.33%)
PIPR +1.57%S&P 500 -2.42%Since first plotted close
4 hours

Loading recent earnings…

Investment thesis

What must happen next

4 MATERIAL PROPOSITIONS
  • Targeted acquisitions and sector hiring (technology, private capital) will sustain above-industry investment banking fee growth by expanding Piper's product set and client relationships, converting into higher advisory mandate wins.StrengtheningMateriality: High

    Revenue growth: 2023 $1,347,967,000 → 2024 $1,525,914,000 → 2025 $1,899,376,000 (annual). If true, recurring fee revenue growth will compound earnings and justify a premium; if false, recent revenue gains will prove cyclical and undo valuation support.

    Watch: Large bulge‑bracket banks or specialist boutiques win increasing share of middle‑market mandates (competition for mandates).

    Supporting sources

    Source notes are factual paraphrases; read the original disclosures below.

    Revenue growth: 2023 $1,347,967,000 → 2024 $1,525,914,000 → 2025 $1,899,376,000 (annual).

    Open source ↗
  • Scale in institutional brokerage, trading and research will convert into operating leverage that preserves or expands margins, because higher flow and research-driven client relationships raise fee and trading income faster than fixed costs.StrengtheningMateriality: High

    Net income improved materially: 2023 $85,491,000 → 2024 $181,114,000 → 2025 $281,331,000 (annual). Margin expansion magnifies EPS growth from revenue increases; if operating leverage fails, higher revenue could be offset by rising compensation and tech costs.

    Watch: Escalating compensation to retain/poach talent erodes operating leverage.

    Supporting sources

    Source notes are factual paraphrases; read the original disclosures below.

    Net income improved materially: 2023 $85,491,000 → 2024 $181,114,000 → 2025 $281,331,000 (annual).

    Open source ↗
  • Elevated cash and equity balances provide Piper the capacity to warehouse positions, underwrite deals and make bolt-on acquisitions without disrupting operations, reducing earnings volatility and enabling opportunistic share gains.StrengtheningMateriality: Medium

    Cash increased: 2023 $383,098,000 → 2024 $482,834,000 → 2025 $809,415,000 (instant/annual balances). Robust liquidity lowers counterparty and funding risk, lets the firm capture market opportunities, and prevents forced asset sales that would hit earnings.

    Watch: Regulatory capital requirements increase materially or change structure, reducing usable liquidity.

    Supporting sources

    Source notes are factual paraphrases; read the original disclosures below.

    Cash increased: 2023 $383,098,000 → 2024 $482,834,000 → 2025 $809,415,000 (instant/annual balances).

    Open source ↗
  • Piper's earnings and cash generation are materially cyclical and will continue to track market volumes—downturns in M&A, underwriting, and trading volumes will show up quickly as lower operating cash flow and net income.StrengtheningMateriality: Medium

    Operating cash flow history shows large swings: 2021 $707,087,000. Volatility means investors must underwrite cyclical drawdowns; the firm needs countercyclical fee sources or capital buffers to smooth returns.

    Watch: If alternative asset management and recurring fee businesses scale sufficiently, they could materially smooth operating cash flow.

    Supporting sources

    Source notes are factual paraphrases; read the original disclosures below.

    Operating cash flow history shows large swings: 2021 $707,087,000.

    Open source ↗
Full investment case & evidence

Loading the original research archive…

Original research

Targeted acquisitions and sector hiring (technology, private capital) will sustain above-industry investment banking fee growth by expanding Piper's product set and client relationships, converting into higher advisory mandate wins. If true, recurring fee revenue growth will compound earnings and justify a premium; if false, recent revenue gains will prove cyclical and undo valuation support.

Scale in institutional brokerage, trading and research will convert into operating leverage that preserves or expands margins, because higher flow and research-driven client relationships raise fee and trading income faster than fixed costs. Margin expansion magnifies EPS growth from revenue increases; if operating leverage fails, higher revenue could be offset by rising compensation and tech costs.

Elevated cash and equity balances provide Piper the capacity to warehouse positions, underwrite deals and make bolt-on acquisitions without disrupting operations, reducing earnings volatility and enabling opportunistic share gains. Robust liquidity lowers counterparty and funding risk, lets the firm capture market opportunities, and prevents forced asset sales that would hit earnings.

Piper's earnings and cash generation are materially cyclical and will continue to track market volumes—downturns in M&A, underwriting, and trading volumes will show up quickly as lower operating cash flow and net income. Volatility means investors must underwrite cyclical drawdowns; the firm needs countercyclical fee sources or capital buffers to smooth returns.

All standing thesis claims
Original report summary

Piper Sandler compounds value by winning middle-market advisory and public finance mandates, cross-selling institutional brokerage and alternative-asset fees, and using a strong balance sheet to amplify underwriting and selective acquisitions.

Evidence assessed Nov 11, 2026. Expand each conclusion for its evidence and what would change it. Thesis evidence—not a buy or sell recommendation.

Bull case and bear case

Bull case and bear case for Piper Sandler Companies

Where the evidence on Piper Sandler Companies stands: Strengthening on the latest evidence (Nov 11, 2026). Of its 4 thesis points, 4 strengthening.

Bull case: what the evidence supports

  • Targeted acquisitions and sector hiring (technology, private capital) will sustain above-industry investment banking fee growth by expanding Piper's product set and client relationships, converting into higher advisory mandate wins.

    sec.gov ↗

  • Scale in institutional brokerage, trading and research will convert into operating leverage that preserves or expands margins, because higher flow and research-driven client relationships raise fee and trading income faster than fixed costs.

    sec.gov ↗

  • Elevated cash and equity balances provide Piper the capacity to warehouse positions, underwrite deals and make bolt-on acquisitions without disrupting operations, reducing earnings volatility and enabling opportunistic share gains.

    sec.gov ↗

  • Piper's earnings and cash generation are materially cyclical and will continue to track market volumes—downturns in M&A, underwriting, and trading volumes will show up quickly as lower operating cash flow and net income.

    sec.gov ↗

Bear case: what would count against it

  • Large bulge‑bracket banks or specialist boutiques win increasing share of middle‑market mandates (competition for mandates).

    sec.gov ↗

  • Escalating compensation to retain/poach talent erodes operating leverage.

    sec.gov ↗

  • Regulatory capital requirements increase materially or change structure, reducing usable liquidity.

    sec.gov ↗

Thesis-Break Engine

Thesis-break watch · Piper Sandler Companies

Loading the break-condition record for Piper Sandler Companies.

How the Thesis-Break Engine works →Historical outcomes are measured against the market after past breaks of the same kind, across all companies. Not a prediction.

MARKET + FINANCIAL SNAPSHOT

The numbers behind the thesis

Sourced from filings and market data

What Changed

  1. Mixed
    Reported results of operations (earnings release).

    Piper Sandler Companies filed an SEC 8-K on 2026-10-30: Reported results of operations (earnings release). It is a dated development that tests the current thesis.

  2. Mixed
    Director or principal officer change.

    Piper Sandler Companies filed an SEC 8-K on 2026-09-22: Director or principal officer change. It is a dated development that tests the current thesis.

  3. Mixed
    Reported results of operations (earnings release).

    Piper Sandler Companies filed an SEC 8-K on 2026-07-30: Reported results of operations (earnings release). It is a dated development that tests the current thesis.

Risks / falsifiers

What could break the thesis

  • Large bulge‑bracket banks or specialist boutiques win increasing share of middle‑market mandates (competition for mandates).
  • Escalating compensation to retain/poach talent erodes operating leverage.
  • Regulatory capital requirements increase materially or change structure, reducing usable liquidity.
  • If alternative asset management and recurring fee businesses scale sufficiently, they could materially smooth operating cash flow.

PIPR news

Loading headlines…

Financial statements

PIPR income statement

Annual filed results · USD · Oldest to newest. Margins are calculated from the reported figures.

PIPR: quick answers

When does Piper Sandler Companies (PIPR) report earnings next?
Piper Sandler Companies's next results are projected for February 5, 2027, from the dates of its own results filings with the SEC. The company has not confirmed the date. It last reported on October 30, 2026. Earnings calendar
What is PIPR's short interest?
As of October 30, 2026, 2.5M PIPR shares were sold short, 3.54% of its shares outstanding, down 7.5% from the count before. At the stock's average daily volume that is 3.2 days to cover. FINRA publishes the count twice a month. PIPR short interest history
Have members of Congress traded PIPR?
Reports made public in the last 90 days disclose 1 trade in PIPR by 1 filer: 0 purchases and 1 sale. They are filed under the STOCK Act by members of Congress, the President and senior officials. Every disclosed PIPR trade
Which well-known investors own PIPR?
1 of the 37 well-known funds tracked here reported PIPR shares in their latest 13F filing. By share of the fund's portfolio: Bridgewater Associates (Ray Dalio), 0.0%. Fund portfolios

PIPR in well-known investors’ portfolios

1 of 37 funds reported PIPR shares in their latest 13F filing. A 13F shows quarter-end positions and arrives up to 45 days later.

FundOf its portfolioValueChangeQuarter
Ray DalioBridgewater Associates0.01%$1.7M−62.1%Q2 2026

Every fund’s portfolio

ScoutJUST THIS STORY

LET’S MAKE THIS USEFUL · 1 OF 5

How would you like me to explain this?

Tell me what you want from this read. Start with a quick note, then adjust the details. Your other stories stay as they are.

We’ll remember your view of this story. The published article stays unchanged.

THIS STORY’S READING VIEWStandard · The whole picture

Clear explanations with context. Both sides of the evidence.